Zhang et al., 2019 demonstrated that GAS5 inhibits PDGF-bb-induced VSMC proliferation and migration, in part by acting as a competitive endogenous RNA of miR21 and provide additional evidence that GAS5 may be a potential therapeutic candidate for hypertension [12]. Here, GAS5 is linked to hypertensive disorder.